VelaVigo Announces Second Out-Licensing Deal for Bi-specific Antibody
VelaVigo Bio, the U.S. subsidiary of VelaVigo Cayman Limited (VelaVigo), a biotech company with a robust discovery and development platform of multi-specific antibodies and antibody-drug...